Characterization of uveal melanoma clinical trial design: a systematic review to establish an elusive standard of care.

Background: There is currently no FDA or EMA-approved standard of care for metastatic uveal melanoma.Material and methods: A systematic review of all interventional uveal melanoma trials on the Cli...